Skip to main content
Have a personal or library account? Click to login
A Decade of Nasopharyngeal Carcinoma: Survival, Failure Patterns, and Prognostic Factors- A Single Institutional Experience Cover

A Decade of Nasopharyngeal Carcinoma: Survival, Failure Patterns, and Prognostic Factors- A Single Institutional Experience

Open Access
|Nov 2026
Read online

References

  1. Chen YP, Chan AT, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
  2. Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22–30.
  3. Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–24.
  4. Chan ATC, Gregoire V, Lefebvre JL, Licitra L, Felip E; EHNS-ESMOESTRO Guidelines Working Group. Nasopharyngeal cancer: EHNSESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v187–9.
  5. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60(5):1440–50.
  6. Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16(6):645–55.
  7. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310–7.
  8. Xu M, Zang J, Luo S, Wang J, Li X. Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study. BMJ Open. 2021;11(8):e045417.
  9. Dragan T, Chiairi I, Salmon M, Lalami Y, Digonnet A, Lipski S, et al. Long-term outcomes and patient profiles following intensity-modulated radio-chemotherapy for nasopharyngeal cancer in a nonendemic region. Front Oncol. 2026;16:1724193.
  10. Wang XL, Sun DQ, Yang H, Li Y, Li XF, Chang XL, et al. Ten-year outcomes of IMRT with chemotherapy versus IMRT alone for stage II-IVa nasopharyngeal carcinoma: a retrospective study. Discov Oncol. 2025;16(1):1378.
  11. Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381(12): 1124–35.
  12. Xu M, Yang S, Cui E, Wang Z, Li X. Induction chemotherapy for nasopharyngeal carcinoma. BMJ. 2025;389:e081905.
Language: English
Page range: 153 - 161
Published on: Nov 11, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Anusha Haider, Syed Mohsin Raza, Sana Liaquat, Ahmed Ammar, Hamza Shakeel, Afshan Khanum, Asma Rashid, Zaheer Abbas, Muneeb Uddin Karim, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.